Oregon Health and Science University (OSHU)

Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS) (2026) Deroose CM, Leupe H, Hicks RJ, Virgolini I, Braat AJ, Mittra ES, Albert NL, et al. Journal article, Review article Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-daily Oral Paltusotine Treatment (2026) Biller BM, Casagrande A, Elenkova A, Boguszewski CL, Jallad RS, Hu B, Hubina E, et al. Journal article Effect of Oral Semaglutide on Cardiovascular Outcomes in Type 2 Diabetes by Extent of Vascular Disease (2026) Cavender MA, Marx N, Mulvagh SL, Deanfield JE, Buse JB, Inzucchi SE, Pop-Busui R, et al. Journal article MYELOstudy: lymph node stage of aggressiveness in medullary thyroid cancer—a retrospective multi-center study analysis (2026) Papavramidis T, Chorti A, Bakkar S, Raffaelli M, Košec A, Hoang VT, Lim JY, et al. Journal article Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma (2026) Weeda YA, Salgado R, van Herpe F, Sur D, Vieth M, Loi S, Tafti AP, et al. Journal article, Review article Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial (2026) Mann JF, Marx N, Deanfield JE, Emerson SS, Inzucchi SE, McGuire DK, Mulvagh SL, et al. Journal article One-Pot Gateway to Quinazoline–Thiohydantoin Fused Scaffolds and Discovery of Their Antileukemic Activity (2026) Kersting L, Zippel C, Herrmann L, Elbadawi M, Seo EJ, Heckmann F, Saeed ME, et al. Journal article Validation of PARACELSUS score performance for the diagnosis of pyoderma gangrenosum: An international multicenter study with 1403 cases (2026) Moelleken M, Ortega-Loayza AG, Busch D, Erfurt-Berge C, Shinohara MM, Do A, Libertad Ortega Nuñez D, et al. Journal article Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes (2026) Pop-Busui R, Rasmussen S, Deanfield JE, Buse JB, Marx N, Mulvagh SL, Inzucchi SE, et al. Journal article Cholangiocarcinoma 2026: status quo, unmet needs and priorities (2026) Banales JM, Rodrigues PM, Affò S, Andersen JB, Aspichueta P, Boulter L, Bridgewater J, et al. Journal article, Review article